CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients

Intravenous ganciclovir and, increasingly, oral valganciclovir are now considered the mainstay of treatment for cytomegalovirus (CMV) infection or CMV disease. Under certain circumstances, CMV immunoglobulin (CMVIG) may be an appropriate addition or, indeed, alternative. Data on monotherapy with CMV...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Uwe, Solidoro, Paolo, Müller, Veronika, Szabo, Attila, Gottlieb, Jens, Wilkens, Heinrike, Enseleit, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764017/
https://www.ncbi.nlm.nih.gov/pubmed/26900992
http://dx.doi.org/10.1097/TP.0000000000001097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764017/
https://www.ncbi.nlm.nih.gov/pubmed/26900992
http://dx.doi.org/10.1097/TP.0000000000001097

Ejemplares similares